All Videos Channels

Channels

xlmyohaacejjksngxuar

0 Followers

w92sngxo

0 Followers

zmvweonsngxrqwurjusw

0 Followers

xJsnGx

0 Followers

hyfxcsngxg

0 Followers

zlsmeagsbevdesngxtka

0 Followers

ygjwnfydatsngxwabbul

0 Followers
View all
  1. Breaking News | Soligenix, Inc. (Nasdaq: SNGX) | RICH TV LIVE PODCAST

    Breaking News | Soligenix, Inc. (Nasdaq: SNGX) | RICH TV LIVE PODCAST

    75
  2. Soligenix, Inc. (Nasdaq: SNGX) CEO Christopher Schaber - Interview - RICH TV LIVE

    Soligenix, Inc. (Nasdaq: SNGX) CEO Christopher Schaber - Interview - RICH TV LIVE

    15
    2
    61
  3. Hot Stocks: $SNGX, $PEGY, $QURE, $LGVN, $ZAPP, $NVDA, $TSLA, $MUSL, $MUSLF, - RICH TV

    Hot Stocks: $SNGX, $PEGY, $QURE, $LGVN, $ZAPP, $NVDA, $TSLA, $MUSL, $MUSLF, - RICH TV

    42
  5. Revolutionizing Rare Disease Treatment: Introducing Soligenix's Breakthrough HyBryte™

    Revolutionizing Rare Disease Treatment: Introducing Soligenix's Breakthrough HyBryte™

    12
  6. BEST STOCKS TO BUY NOW MAKING 52 WEEK LOWS | $BBLN $ICU $LEXX $IONM $DYNT $VRAY $APTX $SNGX $PRAA

    BEST STOCKS TO BUY NOW MAKING 52 WEEK LOWS | $BBLN $ICU $LEXX $IONM $DYNT $VRAY $APTX $SNGX $PRAA

    1
  8. Marburg. Is This The Cover Story To Account For The Covid 19 Vaxx Deaths.

    Marburg. Is This The Cover Story To Account For The Covid 19 Vaxx Deaths.

    11
    0
    907
  9. September 2023 - Learn How This Company Is Rising to the Challenge of Rare Disease Treatment of Cutaneous T-Cell Lymphoma and Psoriasis

    September 2023 - Learn How This Company Is Rising to the Challenge of Rare Disease Treatment of Cutaneous T-Cell Lymphoma and Psoriasis

    23
  10. May 2023 - Learn How This Company Is Rising to the Challenge of Rare Disease Treatment for Lymphoma and Psoriasis

    May 2023 - Learn How This Company Is Rising to the Challenge of Rare Disease Treatment for Lymphoma and Psoriasis

    11
  11. HyBryte™ by Soligenix: Transforming Cutaneous T-Cell Lymphoma Treatment

    HyBryte™ by Soligenix: Transforming Cutaneous T-Cell Lymphoma Treatment

    17
  12. Soligenix: Late-Stage Biopharma Addressing a $2 Billion Opportunity

    Soligenix: Late-Stage Biopharma Addressing a $2 Billion Opportunity

    3
  13. Soligenix: Illuminating the Future of Rare Disease Therapies

    Soligenix: Illuminating the Future of Rare Disease Therapies

    6
  14. Revolutionizing Health and Safety: Genetic Technologies, Knightscope, and Soligenix

    Revolutionizing Health and Safety: Genetic Technologies, Knightscope, and Soligenix

    9
  15. Soligenix: Advancing Rare Disease Treatments and Fighting Emerging Diseases

    Soligenix: Advancing Rare Disease Treatments and Fighting Emerging Diseases

    3
    0
    6
  16. Uncovering the Future of Healthcare and Clean Energy: Soligenix and SPI Energy Interviews

    Uncovering the Future of Healthcare and Clean Energy: Soligenix and SPI Energy Interviews

    28
  17. Medical Mavericks: BioVie and Soligenix, the Leaders in Life Sciences

    Medical Mavericks: BioVie and Soligenix, the Leaders in Life Sciences

    1
  18. Revolutionizing Rare Disease Treatment: Soligenix's Breakthroughs

    Revolutionizing Rare Disease Treatment: Soligenix's Breakthroughs

  19. Driving Energy Innovation and Isotope Advancements: Interviews with Graphex Group and ASP Isotopes

    Driving Energy Innovation and Isotope Advancements: Interviews with Graphex Group and ASP Isotopes

    1
  20. ASP Isotopes & Soligenix Inc.: Lead Innovators in Isotope Enrichment and Rare Diseases

    ASP Isotopes & Soligenix Inc.: Lead Innovators in Isotope Enrichment and Rare Diseases

    2
  21. Behind the Science: Soligenix and Graphex Group on Medical Advancements and Clean Energy Solutions

    Behind the Science: Soligenix and Graphex Group on Medical Advancements and Clean Energy Solutions

    1
  22. Inside Soligenix: Innovations in Rare Disease Therapies

    Inside Soligenix: Innovations in Rare Disease Therapies

    1